top of page


Robert Schultz, Ph.D.
Founder and CEO

Dr. Schultz has held various Scientific and Executive Management positions during his 40-year career in the pharmaceutical and medical device industries. His expertise in the development of combination products and ability to lead internal and external resources in the start- up environment provides Sollievo with the leadership to successfully navigate the drug development process.

Peter Schineller
Commercial Strategy Advisor

During his 35-year career, Mr. Schineller has held SVP and Chief Commercial Roles at leading drug and diagnostic companies and founded his own start-up Veras Pharmaceuticals., where he was the CCO. Mr. Schineller's role is to guide the company to a marketing and launch strategy that will ensure successful uptake of Proviza post- launch.

M.D., Sc.D.
Regulatory and Clinical

Dr. Waymack is a regulatory consultant, and previously worked as an FDA medical reviewer and special consulting reviewer, responsible for assessing new drug applications and investigational drug applications. Both his consulting and chief medical officer experience with early-stage companies will strengthen the management team in all activities pertaining to the development of Proviza, including regulatory and clinical activities.

Steve King, BPharm
Business Development

Experienced Senior Manager with a 30-year history of working in the Pharmaceutical industry. Strong professional skills in Business Development, Alliance Management, Licensing, CMC Outsourcing, Biotechnology, Drug Development, and Pharmaceutical Project Management. Steve is responsible for identifying, sourcing, and contract negotiations with potential manufacturing partners and suppliers.

bottom of page